Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis

Completed · Phase 2 · Has a placebo group

Conditions studied: Peri-implant Mucositis

In brief

This study seeks to test the recently discovered anti-inflammatory action of statins on inflamed mucosa surrounding dental implants. Hypothesis: The application of 1.2% simvastatin gel will decrease peri-implant inflammation. The pilot study will involve 44 subjects divided into a test and control group. The test group shall receive topical simvastatin gel administered around the implant with a blunt tipped needle. The control group will receive a placebo. Inflammatory state shall be determined at baseline as well as follow up visits at 24 hours, 1 week, and 1 month by clinical indices of inflammation as well as biochemical markers of inflammation gathered from around the implants.

Key facts

Study ID
NCT03400475
Run by
Ahmed Mohamed Mahrous
People needed
46
Starts
2015-04-23
Expected to finish
2016-10-24
Last updated by the study team
2018-12-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.